The three ZNT8 autoantibody variants together improve the diagnostic sensitivity of childhood and adolescent type 1 diabetes

References

• Harjutsalo V, Podar T, Tuomilehto J. Cumulative incidence of type 1 diabetes in 10,168 siblings of Finnish young-onset type 1 diabetic patients. Diabetes. 2005; 54:563–569.
   Google Scholar
• Mrena S, Virtanen SM, Laippala P, Kulmala P, Hannila ML, Akerblom HK, Knip M. Models for predicting type 1 diabetes in siblings of affected children. Diabetes Care. 2006; 29:662–667.
   PubMed Web of Science ®Google Scholar
• Hyttinen V, Kaprio J, Kinnunen L, Koskenvuo M, Tuomilehto J. Genetic liability of type 1 diabetes and the onset age among 22,650 young Finnish twin pairs: A nationwide follow-up study. Diabetes. 2003; 52:1052–1056.
   PubMed Web of Science ®Google Scholar
• Schenker M, Hummel M, Ferber K, Walter M, Keller E, Albert ED, Janka HU, Kastendiek C, Sorger M, Louwen F, Ziegler AG. Early expression and high prevalence of islet autoantibodies for DR3/4 heterozygous and DR4/4 homozygous offspring of parents with type I diabetes: The German BABYDIAB study. Diabetologia. 1999; 42:671–677.
   Google Scholar
• Gale EA, Gillespie KM. Diabetes and gender. Diabetologia. 2001; 44:3–15.
   PubMed Web of Science ®Google Scholar
• Kukko M, Kimpimaki T, Kupila A, Korhonen S, Kulmala P, Savola K, Simell T, Keskinen P, Ilonen J, Simell O, Knip M. Signs of beta-cell autoimmunity and HLA-defined diabetes susceptibility in the Finnish population: The sib cohort from the type 1 diabetes prediction and prevention study. Diabetologia. 2003; 46:65–70.
   Google Scholar
• Concannon P, Rich SS, Nepom GT. Genetics of type 1A diabetes. N Engl J Med. 2009; 360:1646–1654.
   PubMed Web of Science ®Google Scholar
• Aly TA, Ide A, Humphrey K, Barker JM, Steck A, Erlich HA, Yu L, Miao D, Redondo MJ, McFann K, Roberts CM, Babu SR, Norris JM, Eisenbarth GS, Rewers MJ. Genetic prediction of autoimmunity: Initial oligogenic prediction of anti-islet autoimmunity amongst DR3/DR4-DQ8 relatives of patients with type 1A diabetes. J Autoimmun. 2005; 25:40–45.
   Google Scholar
• Walter M, Albert E, Conrad M, Keller E, Hummel M, Ferber K, Barratt BJ, Todd JA, Ziegler AG, Bonifacio E. IDDM2/insulin VNTR modifies risk conferred by IDDM1/HLA for development of type 1 diabetes and associated autoimmunity. Diabetologia. 2003; 46:712–720.
   Google Scholar
• Hermann R, Turpeinen H, Laine AP, Veijola R, Knip M, Simell O, Sipila I, Akerblom HK, Ilonen J. HLA DR-DQ-encoded genetic determinants of childhood-onset type 1 diabetes in Finland: An analysis of 622 nuclear families. Tissue Antigens. 2003; 62:162–169.
   PubMed Web of Science ®Google Scholar
• Graham J, Hagopian WA, Kockum I, Li LS, Sanjeevi CB, Lowe RM, Schaefer JB, Zarghami M, Day HL, Landin-Olsson M, Palmer JP, Janer-Villanueva M, Hood L, Sundkvist G, Lernmark A, Breslow N, Dahlquist G, Blohme G. Genetic effects on age-dependent onset and islet cell autoantibody markers in type 1 diabetes. Diabetes. 2002; 51:1346–1355.
   PubMed Web of Science ®Google Scholar
• Larsson HE, Hansson G, Carlsson A, Cederwall E, Jonsson B, Larsson K, Lynch K, Neiderud J, Lernmark A, Ivarsson SA. Children developing type 1 diabetes before 6 years of age have increased linear growth independent of HLA genotypes. Diabetologia. 2008; 51:1623–1630.
   PubMed Web of Science ®Google Scholar
• Sabbah E, Savola K, Kulmala P, Reijonen H, Veijola R, Vahasalo P, Karjalainen J, Ilonen J, Akerblom HK, Knip M. Disease-associated autoantibodies and HLA-DQB1 genotypes in children with newly diagnosed insulin-dependent diabetes mellitus (IDDM). The Childhood Diabetes in Finland Study Group. Clin Exp Immunol. 1999; 116:78–83.
   PubMedGoogle Scholar
• Yamamoto AM, Deschamps I, Garchon HJ, Roussely H, Moreau N, Beaurain G, Robert JJ, Bach JF. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children. J Autoimmun. 1998; 11:643–650.
   Google Scholar
• Yu L, Rewers M, Gianani R, Kawasaki E, Zhang Y, Verge C, Chase P, Klingensmith G, Erlich H, Norris J, Eisenbarth GS. Antiislet autoantibodies usually develop sequentially rather than simultaneously. J Clin Endocrinol Metab. 1996; 81:4264–4267.
   PubMed Web of Science ®Google Scholar
• Kulmala P, Savola K, Petersen JS, Vahasalo P, Karjalainen J, Lopponen T, Dyrberg T, Akerblom HK, Knip M. Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes. A population-based study. The Childhood Diabetes in Finland Study Group. J Clin Invest. 1998; 101:327–336.
   PubMed Web of Science ®Google Scholar
• Gorus FK, Goubert P, Semakula C, Vandewalle CL, De Schepper J, Scheen A, Christie MR, Pipeleers DG. IA-2-autoantibodies complement GAD65-autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings. The Belgian Diabetes Registry. Diabetologia. 1997; 40:95–99.
   PubMedGoogle Scholar
• Mrena S, Savola K, Kulmala P, Akerblom HK, Knip M. Natural course of preclinical type 1 diabetes in siblings of affected children. Acta Paediatr. 2003; 92:1403–1410.
   Google Scholar
• Hanas R, Lindgren F, Lindblad B. Diabetic ketoacidosis and cerebral oedema in Sweden–a 2-year paediatric population study. Diabet Med. 2007; 24:1080–1085.
   PubMed Web of Science ®Google Scholar
• Wenzlau JM, Moua O, Sarkar SA, Yu L, Rewers M, Eisenbarth GS, Davidson HW, Hutton JC. SlC30A8 is a major target of humoral autoimmunity in type 1 diabetes and a predictive marker in prediabetes. Ann N Y Acad Sci. 2008; 1150:256–259.
   PubMedGoogle Scholar
• Lampasona V, Petrone A, Tiberti C, Capizzi M, Spoletini M, di Pietro S, Songini M, Bonicchio S, Giorgino F, Bonifacio E, Bosi E, Buzzetti R. Zinc transporter 8 antibodies complement GAD and IA-2 antibodies in the identification and characterization of adult-onset autoimmune diabetes: non insulin requiring autoimmune diabetes (NIRAD) 4. Diabetes Care. 2010; 33:104–108.
   PubMed Web of Science ®Google Scholar
• Achenbach P, Lampasona V, Landherr U, Koczwara K, Krause S, Grallert H, Winkler C, Pfluger M, Illig T, Bonifacio E, Ziegler AG. Autoantibodies to zinc transporter 8 and SLC30A8 genotype stratify type 1 diabetes risk. Diabetologia. 2009; 52:1881–1888.
   PubMed Web of Science ®Google Scholar
• Gohlke H, Ferrari U, Koczwara K, Bonifacio E, Illig T, Ziegler AG. SLC30A8 (ZnT8) polymorphism is associated with young age at type 1 diabetes onset. Rev Diabet Stud. 2008; 5:25–27.
   PubMedGoogle Scholar
• De Grijse J, Asanghanwa M, Nouthe B, Albrecher N, Goubert P, Vermeulen I, Van Der Meeren S, Decochez K, Weets I, Keymeulen B, Lampasona V, Wenzlau J, Hutton JC, Pipeleers D, Gorus FK. Predictive power of screening for antibodies against insulinoma-associated protein 2 beta (IA-2beta) and zinc transporter-8 to select first-degree relatives of type 1 diabetic patients with risk of rapid progression to clinical onset of the disease: implications for prevention trials. Diabetologia. 2010; 53:517–524.
   PubMed Web of Science ®Google Scholar
• Kawasaki E, Nakamura K, Kuriya G, Satoh T, Kuwahara H, Kobayashi M, Abiru N, Yamasaki H, Eguchi K. Autoantibodies to insulin, insulinoma-associated antigen-2, and zinc transporter 8 improve the prediction of early insulin requirement in adult-onset autoimmune diabetes. J Clin Endocrinol Metab. 2010; 95:707–713.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2007; 30 Suppl 1: S42–S47.
   PubMedGoogle Scholar
• Landin-Olsson M, Arnqvist HJ, Blohme G, Littorin B, Lithner F, Nystrom L, Schersten B, Sundkvist G, Wibell L, Ostman J, Lernmark A. Appearance of islet cell autoantibodies after clinical diagnosis of diabetes mellitus. Autoimmunity. 1999; 29:57–63.
   PubMed Web of Science ®Google Scholar
• Williams AJ, Bingley PJ, Bonifacio E, Palmer JP, Gale EA. A novel micro-assay for insulin autoantibodies. J Autoimmun. 1997; 10:473–478.
   PubMed Web of Science ®Google Scholar
• Larsson HE, Lynch K, Lernmark B, Hansson G, Lernmark A, Ivarsson SA. Relationship between increased relative birthweight and infections during pregnancy in children with a high-risk diabetes HLA genotype. Diabetologia. 2007; 50:1161–1169.
   PubMed Web of Science ®Google Scholar
• Vaziri-Sani F, Oak S, Radtke J, Lernmark A, Lynch K, Agardh CD, Cilio CM, Lethagen AL, Ortqvist E, Landin-Olsson M, Torn C, Hampe CS. ZnT8 autoantibody titers in type 1 diabetes patients decline rapidly after clinical onset. Autoimmunity. 2010; 43:598–607.
   PubMed Web of Science ®Google Scholar
• Kiviniemi M, Hermann R, Nurmi J, Ziegler AG, Knip M, Simell O, Veijola R, Lovgren T, Ilonen J. A high-throughput population screening system for the estimation of genetic risk for type 1 diabetes: An application for the TEDDY (the Environmental Determinants of Diabetes in the Young) study. Diabetes Technol Ther. 2007; 9:460–472.
   PubMed Web of Science ®Google Scholar
• Larsson HE, Lynch K, Lernmark B, Nilsson A, Hansson G, Almgren P, Lernmark A, Ivarsson SA, Diabetes-associated HLA. genotypes affect birthweight in the general population. Diabetologia. 2005; 48:1484–1491.
   PubMed Web of Science ®Google Scholar
• Lynch KF, Lernmark B, Merlo J, Cilio CM, Ivarsson SA, Lernmark A. Cord blood islet autoantibodies and seasonal association with the type 1 diabetes high-risk genotype. J Perinatol. 2008; 28:211–217.
   PubMed Web of Science ®Google Scholar
• Viera AJ, Garrett JM. Understanding interobserver agreement: The kappa statistic. Fam Med. 2005; 37:360–363.
   PubMed Web of Science ®Google Scholar
• Eisenbarth GS, Jeffrey J. The natural history of type 1A diabetes. Arq Bras Endocrinol Metabol. 2008; 52:146–155.
   Google Scholar
• Knip M, Siljander H. Autoimmune mechanisms in type 1 diabetes. Autoimmun Rev. 2008; 7:550–557.
   PubMed Web of Science ®Google Scholar
• Gupta M, Graham J, McNeeny B, Zarghami M, Landin-Olsson M, Hagopian WA, Palmer J, Lernmark A, Sanjeevi CB. MHC class I chain-related gene-A is associated with IA2 and IAA but not GAD in Swedish type 1 diabetes mellitus. Ann NY Acad Sci. 2006; 1079:229–239.
   Google Scholar
• Borg H, Marcus C, Sjoblad S, Fernlund P, Sundkvist G. Insulin autoantibodies are of less value compared with islet antibodies in the clinical diagnosis of autoimmune type 1 diabetes in children older than 3 yr of age. Pediatr Diabetes. 2002; 3:149–154.
   Google Scholar
• Lindberg B, Ivarsson SA, Landin-Olsson M, Sundkvist G, Svanberg L, Lernmark A. Islet autoantibodies in cord blood from children who developed type I (insulin-dependent) diabetes mellitus before 15 years of age. Diabetologia. 1999; 42:181–187.
   PubMed Web of Science ®Google Scholar
• Elfving M, Lindberg B, Lynch K, Mansson M, Sundkvist G, Lernmark A, Ivarsson SA. Number of islet autoantibodies present in newly diagnosed type 1 diabetes children born to non-diabetic mothers is affected by islet autoantibodies present at birth. Pediatr Diabetes. 2008; 9:127–134.
   Google Scholar
• Hirai H, Miura J, Hu Y, Larsson H, Larsson K, Lernmark A, Ivarsson SA, Wu T, Kingman A, Tzioufas AG, Notkins AL. Selective screening of secretory vesicle-associated proteins for autoantigens in type 1 diabetes: VAMP2 and NPY are new minor autoantigens. Clin Immunol. 2008; 127:366–374.
   Google Scholar
• Yu L, Cuthbertson DD, Maclaren N, Jackson R, Palmer JP, Orban T, Eisenbarth GS, Krischer JP. Expression of GAD65 and islet cell antibody (ICA512) autoantibodies among cytoplasmic ICA+ relatives is associated with eligibility for the diabetes prevention trial-type 1. Diabetes. 2001; 50:1735–1740.
   Google Scholar
• Bingley PJ, Mahon JL, Gale EA. Insulin resistance and progression to type 1 diabetes in the European Nicotinamide Diabetes Intervention Trial (ENDIT). Diabetes Care. 2008; 31:146–150.
   Google Scholar